The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Nonparametric Estimation from Incomplete Observations
Abstract
In lifetesting, medical follow-up, and other fields the observation of the time of occurrence of the event of interest (called a death) may be prevented for some of the items of the sample by the previous occurrence of some other event (called a loss). Losses may be either accidental or controlled, the latter resulting from a decision to terminate certain observations. In either case it is usually assumed in this paper that the lifetime (age at death) is independent of the potential loss time; in practice this assumption deserves careful scrutiny. Despite the resulting incompleteness of the data, it is desired to estimate the proportion P(t) of items in the population whose lifetimes would exceed t (in the absence of such losses), without making any assumption about the form of the function P(t). The observation for each item of a suitable initial event, marking the beginning of its lifetime, is presupposed. For random samples of size N the product-limit (PL) estimate can be defined as follows: List and label the N observed lifetimes (whether to death or loss) in order of increasing magnitude, so that one has 0≤t 1ǐ≤t 2ǐ≤ … ≤t N ǐ. Then P(t)= II. [(N – r)/(N – r + 1)], where r assumes those values for which tr ≤t and for which tr ǐ measures the time to death. This estimate is the distribution, unrestricted as to form, which maximizes the likelihood of the observations. Other estimates that are discussed are the actuarial estimates (which are also products, but with the number of factors usually reduced by grouping); and reduced-sample (RS) estimates, which require that losses not be accidental, so that the limits of observation (potential loss times) are known even for those items whose deaths are observed. When no losses occur at ages less than t, the estimate of P(t) in all cases reduces to the usual binomial estimate, namely, the observed proportion of survivors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This 1-year persistence rate is substantially lower than the more than 85% persistence rate reported in many weight loss GLP-1 treatment RCTs 7,13,[27][28][29] and the real-world diabetes treatment GLP-1 studies with around 50% persistent.15,16”
From Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. (2024) · cites this paper as [15]
In the citing paper
“Real-world T2DM treatment GLP-1 studies have found 1 year persistence rates at around 50%. 15,16”
From Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. (2024) · cites this paper as [15]
Citations
Cites
Journal of The American Statistical Association
Fienberg, S. E. (2004) · Encyclopedia of Statistical Sciences · doi:10.1002/0471667196.ess1317 · Cited by 6,289
Survival curve for cancer patients following treatment
Berkson, J., & Gage, R. P. (1952) · Journal of the American Statistical Association · doi:10.1080/01621459.1952.10501187 · Cited by 889
Epstein, B., & Sobel, M. (1953) · Journal of the American Statistical Association · doi:10.1080/01621459.1953.10483488 · Cited by 485
An Analysis of Some Failure Data
Davis, D. J. (1952) · Journal of the American Statistical Association · doi:10.1080/01621459.1952.10501160 · Cited by 452
Some Theorems Relevant to Life Testing from an Exponential Distribution
Epstein, B., & Sobel, M. (1954) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177728793 · Cited by 319
Irwin, J. O. (1949) · Journal of Hygiene · doi:10.1017/s0022172400014443 · Cited by 182
THE NATURAL DURATION OF CANCER.
(1926) · The Lancet · doi:10.1016/s0140-6736(01)26538-6 · Cited by 163
Epstein, B., & Sobel, M. (1953) · Journal of the American Statistical Association · doi:10.2307/2281004 · Cited by 162
Stephan, F. F. (1945) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177731170 · Cited by 119
XXVII. On the statistical estimation of mean life-times
Bartlett, M. S. (1953) · The London Edinburgh and Dublin Philosophical Magazine and Journal of Science · doi:10.1080/14786440308520304 · Cited by 96
Research works printed but not linked: 12
- Berkson , J. and Gage , R. P. 1950 . “Calculation of survival rates for cancer,” . Proceedings of the Staff Meetings of the Mayo Clinic , 25 : 270 – 86 . · DOI
- Böhmer , P. E. 1912 . “Theorie der unabhängigen Wahrscheinlichkeiten,” 327 – 43 . Rapports, Mémoires et Procès-verbaux de Septième Congrès International d'Actuaires, Amsterdam, 2
- Cornfield , J. 1950 . “Cancer illness among residents in Atlanta, Georgia,” Public Health Service Publication No. 13, Cancer Morbidity Series No. 1
- Fix , Evelyn . “Practical implications of certain stochastic models on different methods of follow-up studies,” . Paper presented at 1951 annual meeting of the Western Branch . 1951 . November 1 . American Public Health Association .
- Fix , Evelyn and Neyman , J. 1951 . “A simple stochastic model of recovery, relapse, death and loss of patients,” . Human Biology , 23 : 205 – 41 .
- Greville , T. N. E. 1948 . “Mortality tables analyzed by cause of death,” . In The Record , Vol. 37 , 283 – 94 . American Institute of Actuaries .
- Hald , A. 1949 . “Maximum likelihood estimation of the parameters of a normal distribution which is truncated at a known point,” . Skandinavisk Aktuarietidskrift , 32 : 119 – 34 .
- Harris , T. E. , Meier , P. and Tukey , J. W. 1950 . “Timing of the distribution of events between observations,” . Human Biology , 22 : 249 – 70 .
- Jablon , Seymour . June 14 1951 . “Testing of survival rates as computed from life tables,” June 14 , unpublished memorandum
- Kahn , H. A. and Mantel , Nathan . “Variance of estimated proportions withdrawing in single decrement follow-up studies when cases are lost from observation,” unpublished manuscript
- Littell , A. S. 1952 . “Estimation of the T-year survival rate from follow-up studies over a limited period of time,” . Human Biology , 24 : 87 – 116 .
- Seal , H. L. 1954 . “The estimation of mortality and other decremental probabilities,” . Skandinavisk Aktuarietidskrift , 37 : 137 – 62 .
Cited by
Sorted by citations
Items 101–200 of 1,378
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.
Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., Markesbery, W. R., Foon, K. A., & Young, B. A. (1998) · PubMed · doi:10.1001/jama.280.17.1485 · Cited by 1,913
Cartron, G., Dacheux, L., Salles, G. A., Solal‐Céligny, P., BARDOS, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,954
Van Cutsem, E., Köhne, C.-H., Láng, I., Folprecht, G., Nowacki, M. P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5091 · Cited by 1,882
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911123 · Cited by 1,835
The Empirical Distribution Function with Arbitrarily Grouped, Censored and Truncated Data
Turnbull, B. W. (1976) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.2517-6161.1976.tb01597.x · Cited by 1,835
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Silverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D. A., Powell, B. L., DeCastro, C. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.117 · Cited by 1,814
Regression modelling strategies for improved prognostic prediction
Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030207 · Cited by 1,804
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
Motzer, R. J., Mazumdar, M., Bacik, J., Berg, W. J., Amsterdam, A., & Ferrara, J. M. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2530 · Cited by 1,797
Rastogi, P., Anderson, S. J., Bear, H. D., Geyer, C. E., Kahlenberg, M. S., Robidoux, A., Margolese, R. G., Hoehn, J. L., Vogel, V. G., Dakhil, S. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0235 · Cited by 1,789
Binet, J., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J.-E., Vaugier, G., Potron, G., Colona, P., Oberling, F., et al. (1981) · Cancer · doi:10.1002/1097-0142(19810701)48:1 · Cited by 1,776
Sweeney, M. O., Hellkamp, A. S., Ellenbogen, K. A., Greenspon, A. J., Freedman, R. A., Lee, K. L., & Lamas, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000072769.17295.b1 · Cited by 1,773
Bernier, J., Cooper, J. S., Pajak, T. F., Glabbeke, M. M. V., Bourhis, J., Forastiere, A. A., Özşahin, M., Jacobs, J. R., Jassem, J., Ang, K., et al. (2005) · Head & Neck · doi:10.1002/hed.20279 · Cited by 1,765
Heinemann, V., von Weikersthal, L. F., Decker, T., Kiani, A., Vehling-Kaiser, U., Al-Batran, S.-E., Heintges, T., Lerchenmüller, C., Kahl, C., Seipelt, G., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70330-4 · Cited by 1,740
Adelstein, D. J., Li, Y., Adams, G. L., Wagner, H., Kish, J. A., Ensley, J. F., Schuller, D. E., & Forastiere, A. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.008 · Cited by 1,747
Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality.
Broderick, J. P., Brott, T. G., Duldner, J. E., Tomsick, T. A., & Huster, G. A. (1993) · Stroke · doi:10.1161/01.str.24.7.987 · Cited by 1,744
Thiede, C., Steudel, C., Mohr, B., Schaich, M. A., Schäkel, U., Platzbecker, U., Wermke, M., Bornhäuser, M., Ritter, M., Neubauer, A., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4326 · Cited by 1,719
Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., Kotb, M., Gillies, S. D., King, M., Mangada, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6477 · Cited by 1,781
Frequency domain measures of heart period variability and mortality after myocardial infarction
Bigger, J. T., Fleiss, J. L., Steinman, R. C., Rolnitzky, L. M., Kleiger, R. E., & Rottman, J. N. (1992) · Circulation · doi:10.1161/01.cir.85.1.164 · Cited by 1,712
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
Stroke Prevention in Atrial Fibrillation Study. Final results.
Prevention, S., & Atrial Fibrillation Investigators (1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
Lánczky, A., & Győrffy, B. (2021) · Journal of Medical Internet Research · doi:10.2196/27633 · Cited by 1,694
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
Wang, M. L., Rule, S., Martin, P., Goy, A., Auer, R., Kahl, B. S., Jurczak, W., Advani, R. H., Romaguera, J. E., Williams, M. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306220 · Cited by 1,685
Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.
Verdecchia, P., Porcellati, C., Schillaci, G., Borgioni, C., Ciucci, A., Battistelli, M., Guerrieri, M., Gatteschi, C., Zampi, I., Santucci, A., et al. (1994) · Hypertension · doi:10.1161/01.hyp.24.6.793 · Cited by 1,671
Hilibrand, A. S., Carlson, G. D., Palumbo, M. A., Jones, P. K., & Bohlman, H. H. (1999) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199904000-00009 · Cited by 1,669
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
WALKER, M. D., Alexander, E., Hunt, W. E., MacCarty, C. S., Mahaley, M. S., Mealey, J., Norrell, H., Owens, G., Ransohoff, J., Wilson, C. B., et al. (1978) · Journal of neurosurgery · doi:10.3171/jns.1978.49.3.0333 · Cited by 1,684
Sirveaux, F., Favard, L., Oudet, D., Huquet, D., Walch, G., & Molé, D. (2004) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.86b3.14024 · Cited by 1,639
Motzer, R. J., Michaelson, M. D., Redman, B. G., Hudes, G. R., Wilding, G., Figlin, R. A., Ginsberg, M. S., Kim, S. T., Baum, C. M., DePrimo, S. E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2574 · Cited by 1,630
Bokemeyer, C., Bondarenko, I., Makhson, A. M., Hartmann, J. T., Aparicio, J., de Braud, F., Donea, S., Ludwig, H., Schuch, G., Stroh, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8397 · Cited by 1,646
Gisselbrecht, C., Glaß, B., Mounier, N., Gill, D. S., Linch, D. C., Trněný, M., Bosly, A., Ketterer, N., Shpilberg, O., Hagberg, H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1618 · Cited by 1,639
Minsky, B. D., Pajak, T. F., Ginsberg, R. J., Pisansky, T. M., Martenson, J. A., Komaki, R. U., Okawara, G. S., Rosenthal, S. A., & Kelsen, D. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1167 · Cited by 1,614
Shaw, E., Scott, C., Souhami, L., Dinapoli, R. P., Kline, R. W., Loeffler, J. S., & Farnan, N. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00507-6 · Cited by 1,610
Shimoyama, M., & members of The Lymphoma Study Group (1984–87) (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08051.x · Cited by 1,608
Canadian Implantable Defibrillator Study (CIDS)
Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., Mitchell, L. B., Green, M. S., Klein, G. J., & O’Brien, B. (2000) · Circulation · doi:10.1161/01.cir.101.11.1297 · Cited by 1,601
Slovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. P., Theil, K. S., Mohamed, A. N., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4075 · Cited by 1,600
O’Sullivan, B., Davis, A. M., TURCOTTE, R. E., Bell, R. S., Catton, C., Chabot, P., Wunder, J. S., Kandel, R. A., Goddard, K., Sadura, A., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09292-9 · Cited by 1,602
Motzer, R. J., Bacik, J., Murphy, B. A., Russo, P., & Mazumdar, M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.1.289 · Cited by 1,575
Timmerman, R. D., McGarry, R. C., Yiannoutsos, C. T., Papiez, L. S., Tudor, K., Deluca, J., Ewing, M. M., Abdulrahman, R., DesRosiers, C. M., Williams, M. D., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.5937 · Cited by 1,556
Cappuzzo, F., Hirsch, F. R., Rossi, E., Bartolini, S., Ceresoli, G. L., Bemis, L., Haney, J., Witta, S. E., Danenberg, K. D., Domenichini, I., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji112 · Cited by 1,538
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Whitney, C. W., Sause, W. T., Bundy, B. N., Malfetano, J. H., Hannigan, E. V., Fowler, W. C., Clarke‐Pearson, D. L., & Liao, S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1339 · Cited by 1,526
Visual Tracking: An Experimental Survey
Smeulders, A. W. M., Chu, D. M., Cucchiara, R., Calderara, S., Dehghan, A., & Shah, M. A. (2014) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2013.230 · Cited by 1,527
Packer, D. L., Mark, D. B., Robb, R. A., Monahan, K. H., Bahnson, T. D., Poole, J. E., Noseworthy, P. A., Rosenberg, Y., Jeffries, N. O., Mitchell, L. B., et al. (2019) · JAMA · doi:10.1001/jama.2019.0693 · Cited by 1,538
Kwon, E. D., Drake, C. G., Scher, H. I., Fizazi, K., Bossi, A., van den Eertwegh, A. J. M., Krainer, M., Houede, N., Santos, R., Mahammedi, H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70189-5 · Cited by 1,511
Sehn, L. H., Berry, B., Chhanabhai, M., Fitzgerald, C., Gill, K., Hoskins, P., Klasa, R., Savage, K. J., Shenkier, T., Sutherland, J., et al. (2007) · Blood · doi:10.1182/blood-2006-08-038257 · Cited by 1,473
Furuse, K., Fukuoka, M., Kawahara, M., NISHIKAWA, H., Takada, Y., Kudoh, S., 信之, 片., & Ariyoshi, Y. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2692 · Cited by 1,496
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Offord, J. R., Larson, D. R., Plevak, M. F., & Melton, L. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa01133202 · Cited by 1,475
Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators
Riall, T. S., Yeo, C. J., Cameron, J. L., Koniaris, L. G., Kaushal, S., Abrams, R. A., Sauter, P. K., Coleman, J., Hruban, R. H., & Lillemoe, K. D. (2000) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(00)80105-5 · Cited by 1,482
Tawbi, H. A., Burgess, M., Bolejack, V., Van Tine, B. A., Schuetze, S. M., Hu, J., D'Angelo, S., Attia, S., Riedel, R. F., Priebat, D. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30624-1 · Cited by 1,452
Kück, K., Cappato, R., Siebels, J., & Rüppel, R. (2000) · Circulation · doi:10.1161/01.cir.102.7.748 · Cited by 1,474
The management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
Albain, K. S., Swann, R. S., Rusch, V. W., Turrisi, A. T., Shepherd, F. A., Smith, C. J., Chen, Y., Livingston, R. B., Feins, R. H., Gandara, D. R., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60737-6 · Cited by 1,472
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Mayer, R. J., Davis, R. B., Schiffer, C. A., Berg, D. T., Powell, B. L., Schulman, P., Omura, G. A., Moore, J. O., McIntyre, O. R., & Frei, E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410063311402 · Cited by 1,427
Giacchetti, S., Perpoint, B., Zidani, R., Bail, N. L., Faggiuolo, R., Focan, C., Chollet, P. J. M., Llory, J., Letourneau, Y., Coudert, B. P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.136 · Cited by 1,404
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R. G., Vick, N. A., Black, K. L., Sisti, M. B., Brem, S. S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,390
Aghajanian, C. A., Blank, S. V., Goff, B. A., Judson, P. L., Teneriello, M. G., Husain, A., Sovak, M. A., Yi, J., & Nycum, L. R. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.0505 · Cited by 1,384
Waldo, A. L., Camm, A. J., deRuyter, H., Friedman, P. L., MacNeil, D. J., Pauls, J. F., Pitt, B., Pratt, C. M., Schwartz, P. J., & Veltri, E. P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02149-6 · Cited by 1,373
Kumar, S. K., Dispenzieri, A. A., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Pandey, S., Kapoor, P., Dingli, D., Hayman, S. R., Leung, N., et al. (2013) · Leukemia · doi:10.1038/leu.2013.313 · Cited by 1,383
Incidence and Prognosis of Syncope
Soteriades, E. S., Evans, J. C., Larson, M. G., Chen, M. H., Chen, L., Benjamin, E. J., & Levy, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012407 · Cited by 1,364
Clinical Prediction Rules: Applications and Methodological Standards
Wasson, J. H., Sox, H. C., Neff, R. K., & Goldman, L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509263131306 · Cited by 1,357
Conroy, T., Bosset, J.-F., Etienne, P.-L., Rio, E., François, É., Mesgouez‐Nebout, N., Vendrely, V., Artignan, X., Bouché, O., Gargot, D., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00079-6 · Cited by 1,354
Habermann, T. M., Weller, E. A., Morrison, V. A., Gascoyne, R. D., Cassileth, P. A., Cohn, J. B., Dakhil, S. R., Woda, B. A., Fisher, R. I., Peterson, B. A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1003 · Cited by 1,353
Tepper, J. E., Krasna, M. J., Niedzwiecki, D., Hollis, D. R., Reed, C. E., Goldberg, R. M., Kiel, K. D., Willett, C. G., Sugarbaker, D. J., & Mayer, R. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9593 · Cited by 1,352
Fu, K. K., Pajak, T. F., Trotti, A., Jones, C. U., Spencer, S. A., Phillips, T. L., Garden, A. S., Ridge, J. A., Cooper, J. S., & Ang, K. K. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00663-5 · Cited by 1,350
Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
Kelsen, D. P., Ginsberg, R., Pajak, T. F., Sheahan, D. G., Gunderson, L., Mortimer, J., Estes, N., Haller, D. G., Ajani, J., Kocha, W., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392704 · Cited by 1,343
Follicular lymphoma international prognostic index
Solal-Céligny, P. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0036-3 · Cited by 1,339
Lefebvre, J.-L., Chevalier, D., Luboinski, B., Kirkpatrick, A., Collette, L., & Sahmoud, T. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.13.890 · Cited by 1,328
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age
Lloyd-Jones, D. M., Leip, E. P., Larson, M. G., D’Agostino, R. B., Beiser, A., Wilson, P. W. F., Wolf, P. A., & Levy, D. (2006) · Circulation · doi:10.1161/circulationaha.105.548206 · Cited by 1,298
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
List, A., Dewald, G., Bennett, J., Giagounidis, A., Raza, A., Feldman, E., Powell, B., Greenberg, P., Thomas, D., Stone, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061292 · Cited by 1,319
Sedlis, A., Bundy, B. N., Rotman, M. Z., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5387 · Cited by 1,318
Nordlinger, B., Sørbye, H., Glimelius, B. L. G., Poston, G. J., Schlag, P. M., Rougier, P. R., Bechstein, W. O., Primrose, J. M., Walpole, E. T., Finch-Jones, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70447-9 · Cited by 1,313
Hughes, K. S., Schnaper, L. A., Bellon, J. R., Cirrincione, C., Berry, D. A., McCormick, B. L., Muss, H. B., Smith, B. L., Hudis, C. A., Winer, E. P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2615 · Cited by 1,310
van Beurden, M., Kate, F. J. W. T., Smits, H. L., Berkhout, R. J. M., de Craen, A. J. M., van der Vange, N., Lammes, F. B., & ter Schegget, J. (1995) · Cancer · doi:10.1002/1097-0142(19950615)75:12 · Cited by 123
Forastiere, A. A., Zhang, Q., Weber, R. S., Maor, M. H., Goepfert, H., Pajak, T. F., Morrison, W. H., Glisson, B. S., Trotti, A., Ridge, J. A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.6097 · Cited by 1,291
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas
Smith, J. S., Chang, E. F., Lamborn, K. R., Chang, S. M., Prados, M. D., Cha, S., Tihan, T., VandenBerg, S., McDermott, M. W., & Berger, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9337 · Cited by 1,283
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221401 · Cited by 1,285
Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice
Paris, F., FUKS, Z. Y., Kang, A. D., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz‐Friedman, A., Cordon‐Cardo, C., & Kolesnick, R. (2001) · Science · doi:10.1126/science.1060191 · Cited by 1,281
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259
PD-1 Blockade with pembrolizumab in advanced Merkel-cell carcinoma
Nghiem, P. T., Bhatia, S., Lipson, E. J., Kudchadkar, R. R., Miller, N. J., Annamalai, L., Berry, S., Chartash, E. K., Daud, A., Fling, S. P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603702 · Cited by 1,258
Cervantes, F., Dupriez, B., Pereira, A., Passamonti, F., Reilly, J. T., Morra, E., Vannucchi, A. M., Mesa, R. A., Demory, J., Barosi, G., et al. (2008) · Blood · doi:10.1182/blood-2008-07-170449 · Cited by 1,256
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
Doki, Y., Ajani, J. A., Kato, K., Xu, J., Wyrwicz, L., Motoyama, S., Ogata, T., Kawakami, H., Hsu, C.-H., Adenis, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2111380 · Cited by 1,271
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,248
Telemonitoring in patients with heart failure
Chaudhry, S. I., Mattera, J. A., Curtis, J. P., Spertus, J. A., Herrin, J., Lin, Z., Phillips, C. O., Hodshon, B. V., Cooper, L. S., & Krumholz, H. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1010029 · Cited by 1,232
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
The Cancer of the Liver Italian Program (Clip) Investigators (1998) · Hepatology · doi:10.1002/hep.510280322 · Cited by 1,240
National Cooperative Crohn's Disease Study: Results of drug treatment
Summers, R. W., Switz, D. M., Sessions, J. T., Becktel, J. M., Best, W. R., Kern, F., & Singleton, J. W. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90385-8 · Cited by 1,238
The Efficiency of Cox's Likelihood Function for Censored Data
Efron, B. (1977) · Journal of the American Statistical Association · doi:10.1080/01621459.1977.10480613 · Cited by 1,240
Stewart, L. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08091-1 · Cited by 1,232
Hachamovitch, R., Berman, D. S., Shaw, L. J., Kiat, H., Cohen, I., Cabico, J. A., Friedman, J. D., & Diamond, G. A. (1998) · Circulation · doi:10.1161/01.cir.97.6.535 · Cited by 1,221
Aaronson, K. D., Schwartz, J. S., Chen, T.-M., Wong, K.-L., Goin, J. E., & MANCINI, D. M. (1997) · Circulation · doi:10.1161/01.cir.95.12.2660 · Cited by 1,182
Gléhen, O., Kwiatkowski, F., Sugarbaker, P. H., Elias, D. M., Levine, E. A., Simone, M. D., Barone, R. M. E., Yonemura, Y., Cavaliere, F., Quénet, F., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.012 · Cited by 1,179
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Mohr, J. P., Thompson, J. L. P., Lazar, R. M., Levin, B., Sacco, R. L., Furie, K. L., Kistler, J. P., Albers, G. W., Pettigrew, L. C., Adams, H. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011258 · Cited by 1,168
Hunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winick, N. J., Reaman, G. H., & Carroll, W. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8018 · Cited by 1,177
Witzig, T. E., Gordon, L. I., Cabanillas, F., Czuczman, M. S., Emmanouilides, C. E., Joyce, R., Pohlman, B. L., Bartlett, N. L., Wiseman, G. A., Padre, N. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.076 · Cited by 1,171
Cancer mortality at very old ages
Smith, D. W. E. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7 · Cited by 61
Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., DeSimone, L., Coltorti, F., Bloise, R., Keegan, R., et al. (2002) · Circulation · doi:10.1161/01.cir.0000020013.73106.d8 · Cited by 1,163
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H. J., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,204
LeVoyer, T. E., Sigurdson, E. R., Hanlon, A. L., Mayer, R. J., Macdonald, J. S., Catalano, P. J., & Haller, D. G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.062 · Cited by 1,151
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Monclair, T. F., Brodeur, G. M., Ambros, P. F., Brisse, H. J., Cecchetto, G., Holmes, K., Kaneko, M., London, W. B., Matthay, K. K., Nuchtern, J. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6876 · Cited by 1,149
Metadata
- Authors
- Kaplan, E. L., & Meier, P.
- Affiliations
- University of California Radiation Laboratory
- University of Chicago (US)
- Venue
- Journal of the American Statistical Association
- Publisher
- Informa UK Limited
- Published
- 1958-06
- Volume
- 53
- Issue
- 282
- Pages
- 457-481
- ISSN
- 0162-1459 (ISSN-L)
- 1537-274X
- OpenAlex
- W4293241248
- Cited by
- 39,158
- References
- 16
- Citations by year
- 2026: 886 · 2025: 862 · 2024: 915 · 2023: 1025 · 2022: 1026 · 2021: 1078 · 2020: 1028 · 2019: 909 · 2018: 944 · 2017: 965 · 2016: 950 · 2015: 961 · 2014: 1137 · 2013: 1046 · 2012: 1056
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Statistical Association (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Distribution Estimation and Applications
- Physical Sciences › Mathematics › Statistics and Probability › Probability and Statistical Research
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Inference
- Keywords
- nonparametric estimation, censored data, survival analysis, Kaplan-Meier estimator, lifetime distributions, clinical follow-up
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review